Among our top contributors in Q4 were Argenx, Lam Research and Insmed. Among our biggest detractors in Q4 were Oracle, ...
We overlay our investment process with broad knowledge of the global economy. We overlay the security selection and capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results